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Summary
Myxomatous mitral-valve prolapse (MMVP), also called
Barlow disease, is a common cardiac abnormality and
affects up to 5% of the population. It is characterized
by an excess of tissue that leads to billowing of the mitral
leaflets, sometimes complicated by prolapse. Typical his-
tological findings include myxomatous degeneration and
degradation of collagen and elastin. Previous reports
have proposed an autosomal dominant inheritance of
the trait, with age- and sex-dependent expression. By
systematic echocardiographic screening of the first-de-
gree relatives of 17 patients who underwent mitral-valve
repair, we have identified four pedigrees showing such
an inheritance. Genomewide linkage analysis of themost
informative pedigree (24 individuals, three generations)
showed a significant linkage for markers mapping to
chromosome 16p, with a two-point maximum LOD
score for D16S3068 ( at ). Linkage toZ = 3.30 v = 0max
D16S3068 was confirmed in a second family (Z =max
at ) but was excluded for the two remaining2.02 v = 0
families, thus demonstrating the genetic heterogeneity of
the disease. Multipoint linkage analysis performed, with
nine additional markers, on the two families with linkage
gave maximum multipoint LOD scores of 5.45 and 5.68
for D16S3133, according to a conservative and a strin-
gent model, respectively. Haplotype analysis defined a
5-cM minimal MMVP-1 locus between D16S3068
(16p11.2) and D16S420 (16p12.1) and a 34-cM max-
imal interval between D16S404 and D16S3068 when
recombination events were taken into account only in
affected individuals. The identification of this locus rep-
resents a first step toward a new molecular classification
of mitral-valve prolapse.
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Introduction
Mitral-valve prolapse (MIM 157700) is a widely used
term that includes a variety of valvular diseases in which
the mitral leaflets fail to appose normally (Barlow and
Pocock 1979; Carpentier et al. 1980). This dysfunction
is frequently encountered, occurring in 2%–8% of the
adult population (Proccaci et al. 1976; Levy and Savage
1987). It generally corresponds to a nonsyndromic idi-
opathic entity, myxomatous mitral-valve prolapse
(MMVP), or Barlow disease. It is characterized by a
series of clinical and electrocardiographic features, rang-
ing from no symptoms (in the vast majority of individ-
uals) to mitral regurgitation, ruptured chordae, endo-
carditis, cerebral embolism, and arrhythmias (Devereux
1976; Bourdarias et al. 1991). The echocardiographic
findings are also variable, including mild to marked sys-
tolic displacement of the mitral leaflets, with varying
mitral-leaflet thickening; dilatation of the mitral annu-
lus; and symptoms ranging from mild telesystolic mitral
insufficiency to severe dysfunction, with elongated and/
or ruptured chordae needing surgical repair (Alpert et
al. 1998). Anatomopathological examination of the mi-
tral leaflets is characterized by tissue redundancy with
myxomatous changes (Frable 1969; Kern and Tucker
1972; Virmani et al. 1987). Histological and ultrastruc-
tural analyses show nonspecific alterations of collagen
and elastin and accumulations of proteoglycans but do
not identify the primary cause of the disease (Tamura et
al. 1995).
Although most cases appear to be sporadic, echocar-
diographic screening of families for MMVP has sug-
gested autosomal dominant inheritance of the trait
(Shappel et al. 1973; Weiss et al. 1975; Bareiss 1976;
Cooper and Abinader 1981) with an age- and sex-de-
pendent expression (Devereux et al. 1982). No system-
atic search for a locus responsible for MMVP has yet
been performed, probably because of the small size of
the pedigrees reported and the likely heterogeneity of the
trait. Mitral-valve prolapse has also been associated with
cardiomyopathies, coronary artery disease, atrial septal
defect, and various heritable disorders such as Marfan
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Figure 1 Echocardiogram of one subject (individual IV.1, kin-
dred 1) with MMVP. a, Two-dimensional echocardiogram in the par-
asternal long-axis view. The arrow indicates the displacement of the
mitral leaflets above the line connecting the midportions of the annular
hinge points (shown as a dashed line). R ight ventricle; L eftV = r V = l
ventricle; A orta; L eft atrium; and PM osterior mitralo = a A = l L = p
leaflet. b, M-mode recording in the parasternal long-axis view. The
arrow indicates the increased thickness of the AML. Its measurement
is performed in the midportion of the leaflet and is shown as a dashed
line.
syndrome, Ehler-Danlos syndrome, and osteogenesis im-
perfecta (Glesby and Pyeritz 1989). This association
with inherited connective-tissue disorders, plus the myx-
omatous degeneration observed in the mitral valves of
patients showing MMVP, has suggested that an abnor-
mality of some component of the connective tissue may
be involved (Whittaker et al. 1987; Tamura et al. 1995).
Previous linkage studies performed on a few affected
pedigrees detected by two-dimensional echocardiograms
have excluded the involvement of four collagen genes
(Henney et al. 1989; Wordworth et al. 1989). Another
rare and severe myxomatous valvular dystrophy inher-
ited in an X-linked fashion (XMVD) has recently been
mapped to chromosome Xq28-qter in a large French
pedigree (Kyndt et al. 1998).
Here we describe four pedigrees including 27 affected
members, showing autosomal dominant transmission of
MMVP. We have performed a genomewide linkage anal-
ysis on the most informative pedigree and have dem-
onstrated significant linkage in this kindred to marker
D16S3068 on chromosome 16. Analysis of the three
additional pedigrees has resulted in the confirmation of
linkage in one family and exclusion in the remaining
families. Refined mapping, by haplotype and multipoint
linkage analysis, done in the families with linkage now
defines a 5-cM minimal or 34-cM maximal interval for
MMVP-1 locus.
Material and Methods
Clinical Evaluation
A double-blind analysis of echocardiograms was per-
formed on the families of 17 probands. Informed consent
was obtained from all the phenotyped individuals (ap-
proval of the Comite´ Consultatif de Protection des Per-
sonnes dans la Recherche Biome´dicale). The propositus
member of each family underwent mitral-valve replace-
ment and MMVP was diagnosed at surgery (Carpentier
et al. 1980). In relatives, MMVP was diagnosed by two-
dimensional echocardiography in the left parasternal
long-axis view (Levine et al. 1988). Investigations were
recorded on videotapes and twice were examined blindly
by two experienced echocardiographists (E.A. and A.B.).
The echographic diagnostic criteria included displace-
ment of the leaflet edges, thickness and redundancy of
the valve, and the diameter of the mitral annulus. The
displacement of each leaflet was measured in the par-
asternal long-axis view above a line connecting the mid-
portions of the annular hinge points (fig. 1a). The thick-
ness of the mitral valve was measured by M-mode
recording (Nishimura et al. 1985) (fig. 1b). To take into
account the great variability in the expression of the
disease (Levy and Savage 1987), subjects were classified
according to the following criteria: (1) a positive diag-
nosis was supported when subjects had a redundant
valve with leaflets 15 mm thick, a total leaflet displace-
ment 18 mm, and evidence of annular dilation; (2) a
strong suspicion occurred when subjects had valve thick-
ness of 4–5 mm or total leaflet displacement of 3–8 mm,
annular dilatation, and frequently late systolic mitral
insufficiency on color flow or continuous wave Doppler;
(3) a weak suspicion was recorded when subjects had
3–4 mm displacement without any mitral regurgitation;
and (4) unaffected subjects were those with a thickness
4 mm and total leaflet displacement 2 mm. To fit
subjects into the three phenotypic classes allowed in link-
age analysis, strongly suspect subjects were later consid-
ered to be affected, and the weakly suspect subjects to
be phenotypically undetermined.
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Marker Analysis
Genotyping was performed for 344 microsatellite
markers from chromosomes 1 to 16 (kit ABI PRISMTM
Linkage Mapping Set, version 2, [PE Biosystems]). The
selected markers were polymorphic (heterozygosity =
.6–.9), informative, and evenly distributed over the hu-
man genome (mean distance between two adjacent
markers of 10 cM). Genomic DNA was amplified by
PCR with primers that were designed to produce frag-
ments over a broad size range and was labeled with three
fluorescent dyes—[FAM], [HEX], and [NED]—to dis-
tinguish between overlapping alleles (standard protocol,
as indicated by the supplier). Allele sizes were compared
between gels, after normalization to control DNA sam-
ple CEPH 1347-02. Signal analysis and genotype deter-
mination were partly automated by use of GENESCAN
and GENOTYPER software.
A similar protocol was used to genotype additional
microsatellite markers to obtain a smaller linkage inter-
val. Nine markers (D16S403, D16S420, D16S499,
D16S3022, D16S3036, D16S3041, D16S3080,
D16S3093, and D16S3133) that mapped to chromo-
some 16 and that were designed by Ge´ne´thon were an-
alyzed by use of fluorescent dye–labeled primers. PCR
reactions were performed in 7.5-ml volumes containing
50 ng genomic DNA, 1 # GeneAmp PCR buffer II
(Roche Molecular System), 2.5 mM MgCl2, 0.25 mM
each dNTP, 0.33 mM each of both primers, and 0.3 U
AmpliTaq Gold DNA polymerase (Roche Molecular
Systems). The mix underwent 30 cycles of amplification,
under suitable annealing conditions, with a GeneAmp
PCR System 9700 thermal cycler (PE Biosystems).
Statistical Analysis
As a correct description of the trait is critical for de-
tecting linkage (Clerget-Darpoux et al. 1986), and as we
observed an incomplete penetrance in young adults in
our families, we excluded unaffected subjects aged !40
years (individuals IV.8, IV.9, IV.10, IV.11, V.2, and V.3
of kindred 1; III.1, III.2, III.13, IV.1, IV.3, IV.4, and IV.5
of kindred 3; IV.1 of kindred 4) from statistical analyses
and assumed a conservative model of inheritance of the
disease. Transmission of the trait was assumed to be
autosomal dominant, with a disease-allele frequency of
.005 and phenocopies at 1% to take into account the
high percentage of sporadic cases. Penetrance was set at
95% for adults aged 140 years. The maximum expected
LOD score was estimated by genotype simulation. By
use of the SLINK program (Ott 1991), 900 replicates
were generated for each pedigree. Two-point LOD scores
were then simulated with the MSIM program (Ott
1991). Simulated allele frequencies were set at .3, .2, .2,
.1, .1, and .1 (heterozygosity equals .8). Two-point LOD
scores for the 344 markers were computed by MLINK
from version 5.2 of the LINKAGE package (Lathrop et
al. 1985; Ott 1991). Allele frequencies for each marker
were obtained online from the Genome Database and
were similar to those observed in our white families.
Recombination fractions were set as identical for males
and females. An admixture test was performed on the
four families, by use of the HOMOG1 program (Ter-
williger and Ott 1994), with two-point LOD scores ob-
tained at seven different recombination fractions. Mul-
tipoint LOD scores were computed by means of the
GENEHUNTER program, version 1.1 (Kruglyak et al.
1996), with the assumption of two different models of
inheritance: the conservative model previously described
and a stringent model characterized by a complete pen-
etrance and no phenocopies. Calculations were per-
formed every 0.5 cM between adjacent markers and 2
cM beyond both frontier markers. Haplotype analysis
and pedigree drawing were done with Cyrillic version
2.1 (Cherwell Scientific).
Results
Clinical and Echocardiographic Characteristics
Since the clinical and echocardiographic classifications
probably reflect multiple pathological conditions
(Glesby and Pyeritz 1989), we restricted our analysis to
first-degree relatives of patients who had undergone mi-
tral-valve repair and had surgically proven MMVP.
Echocardiographic screening of the families of 17 pro-
bands who underwent cardiac surgery identified four
pedigrees as having an autosomal dominant transmis-
sion, each with 5–9 affected members spanning 3–4 gen-
erations (fig. 2). In addition to the probands, who needed
mitral-valve repair for complications of MMVP (severe
mitral regurgitation caused by chordal rupture, in three
cases), most of the affected subjects had either no or
only minor symptoms, such as atypical chest pain, dysp-
nea, or history of palpitations or arrhythmias (table 1).
In these four kindreds, there was no morbid association
with either thoracic or skin abnormalities that might
have evoked a connective-tissue disease or signs of au-
toimmune disease, except for subject III-3 of kindred 1
(Crohn disease) and subject II-1 of kindred 2 (rheu-
matoid arthritis). Systematic measurement of the plasma
concentration of the thyroxin-stimulating hormone was
performed in all subjects and revealed no abnormality.
All kindreds were white: kindred 1 was of Ashkenazi
Jewish origin; kindred 2 originated in western France,
with an ancestor of the 4th generation from Africa; and
kindreds 3 and 4 were from the eastern and western
parts of France, respectively. In this limited number of
subjects and families, there was no clear evidence for
sex-dependent penetrance, because 16 of the 25 affected
subjects were men and 9 were women. We confirmed an
age-dependent penetrance (Weiss et al. 1975; Devereux
et al. 1982), because only 6 (33%) of 18 young offspring
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Table 1
Main Clinical and Echocardiographic Characteristics of the Affected Members of the Four MMVP Pedigrees
KINDRED
AND
INDIVIDUAL AGE SEXa
CLINICAL FINDINGS ECHOCARDIOGRAPHIC PARAMETERS
OTHER
LOCALIZATION
Symptomsb
Click
Systolic
Murmur
Mitral
Regurgitationc
Leaflet
Prolapsed
AML
Thickness
(mm)e
Annulus
Diameter
(mm)eD CP A Time Severity
Kindred 1:
II.1 94 M    No Yes H Severe Fail A leaflet ND ND No
III.1f 69 M   CE No Yes H Severe P  fail A ND ND Tricuspid
III.3 56 M    No Yes M Mild A 2.5 32 No
III.8 70 M    No Yes L Mild P 3.0 25 No
III.9 60 M    No Yes L Mild P 4.5 32 No
IV.1 40 M    Yes Yes M Moderate AP 6.5 34 No
IV.4 25 M    No No L Mild A 5.1 28 No
IV.5 45 F    No Yes L Mild P 3.7 ND No
V.1 15 F    No No No No A 5.0 29 No
Kindred 2:
II.1f 74 F   AF No Yes H Severe A  fail P ND ND Tricuspid
II.2 51 F    Yes Yes H Moderate AP 6.7 38 No
II.3 39 M    No Yes L Mild AP 7.4 37 No
II.4 53 M    No No L Mild A 7.1 36 No
III.1 25 F    No No No No AP 7.1 36 No
III.2 16 F    Yes No L Mild AP 5.9 32 No
Kindred 3:
II.1 69 F    Yes No M Mild A ND ND No
III.1f 43 M    Yes Yes H Severe AP 5.4 33 No
III.3 41 M    No No L Mild A 5.0 28 No
III.4 42 M    No No L Mild A 3.5 31 No
IV.2 27 M    No No L Mild A 5.7 30 No
Kindred 4:
II.2f 69 F   AF No Yes H Severe AP ND ND No
II.3 77 F    No No L Mild P 4.0 29 No
III.1 46 M    Yes Yes M Moderate A 6.1 36 No
III.5 60 F    No No L Mild P 2.5 31 No
IV.2 21 M    Yes Yes M Mild AP 5.1 27 No
a M = male, and F = female.
b D = dyspnea, CP = chest pain, A = history of arrythmias, CE = cerebral embolism, AF = atrial fibrillation,  = symptom present, and 
= symptom absent.
c H = holosystolic, M = midsystolic, and L = late systolic.
d A = anterior leaflet, and P = posterior leaflet. In all cases, presence of a fail leaflet was due to chordal rupture.
e ND = Not determined.
f Index patients who required mitral-valve repair.
of the affected subjects expressed the disease, whereas
14 (50%) of 28 subjects of the preceding generation were
affected. By definition, a systematic leaflet displacement
above the left atrioventricular annulus was observed in
the 25 affected relatives of the four kindreds. By con-
trast, there was an important interfamilial variability of
the thickness of the left anterior mitral leaflet (AML): it
was 15 mm in all positive patients of kindred 2 (mean
6.8  0.6 mm) but was !5 mm in half (7/14) of the
affected relatives of the three remaining families (mean
4.3 1.2 mm, ) (table 1). This increased thick-P ! .001
ness of the left AML of affected patients in kindred 2
was associated with a tendency for a greater dilatation
of the left annulus (35.4  2.2 versus 30.8  3.2 mm,
).P ! .05
Linkage Analysis
Prior evaluation of the maximum expected LOD score
for each pedigree showed that kindred 1 alone could
lead to significant linkage (expected at re-Z = 4.66max
combination fraction [v] 0), whereas kindreds 2, 3, and
4 could only lead to suggestive linkage (expected
, 2.54, and 1.43, respectively, at ). WeZ = 2.06 v = 0max
therefore performed a first-stage genomewide scan of 21
subjects in kindred 1. More than 344 microsatellite
markers were tested, representing chromosomes 1–16;
327 markers gave negative two-point LOD scores,
whereas 6 markers gave LOD scores 11: D2S206
( at ), D16S3075 ( atZ = 1.16 v = 0 Z = 1.41 v =max max
), D16S3103 ( at ), D16S3046.1 Z = 1.99 v = 0max
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Table 3
Detailed Two-Point LOD Scores, for Kindreds 1–4, Obtained for
Four Marker Loci on the Linkage Interval
KINDRED
AND
MARKER
LOD SCORE AT v =
0 .01 .05 .1 .2 .3 .4
Kindred 1:
D16S3075 .94 1.08 1.35 1.41 1.24 .86 .37
D16S3103 1.99 1.98 1.90 1.75 1.36 .89 .38
D16S3046 2.00 1.96 1.80 1.58 1.13 .66 .23
D16S3068 3.30 3.24 3.00 2.69 2.03 1.32 .59
D16S503 .51 .94 1.31 1.35 1.12 .74 .33
Kindred 2:
D16S3075 1.77 1.74 1.61 1.45 1.10 .70 .28
D16S3103 1.76 1.73 1.61 1.45 1.10 .70 .29
D16S3046 .58 .57 .53 .49 .39 .28 .15
D16S3068 2.02 1.99 1.85 1.66 1.27 .82 .34
D16S503 .23 .04 .41 .53 .52 .37 .18
Kindred 3:
D16S3075 NT ) ) ) ) ) )
D16S3103 NT ) ) ) ) ) )
D16S3046 NT ) ) ) ) ) )
D16S3068 2.44 1.94 1.00 .48 .02 .13 .12
D16S503 NT ) ) ) ) ) )
Kindred 4:
D16S3075 .95 .64 .17 .04 .16 .15 .08
D16S3103 1.33 1.30 1.18 1.02 .70 .39 .12
D16S3046 3.52 1.80 .67 .24 .05 .11 .07
D16S3068 .29 .24 .10 .01 .04 .03 .01
D16S503 4.55 2.93 1.48 .80 .22 0 .05
NOTE.—NT = not tested.
Table 2
Two-Point LOD Scores for Kindred 1, Obtained at Different
Recombination Fractions for 13 Marker Loci Ranked from pter to
qter on Chromosome 16
MARKER
LOD SCORE AT v =
0 .01 .05 .1 .2 .3 .4
D16S423 .65 .57 .29 .04 .23 .28 .20
D16S404 2.28 2.24 2.03 1.71 1.10 .63 .27
D16S3075 .94 1.08 1.35 1.41 1.24 .86 .37
D16S3103 1.99 1.98 1.90 1.75 1.36 .89 .38
D16S3046 2.00 1.96 1.80 1.58 1.13 .66 .23
D16S3068 3.30 3.24 3.00 2.69 2.03 1.32 .59
D16S3136 .40 .26 .01 .07 .07 .02 .01
D16S415 .83 .46 .27 .62 .78 .63 .34
D16S503 .51 .94 1.31 1.35 1.12 .74 .33
D16S515 2.62 1.60 .61 .20 .08 .13 .09
D16S516 2.91 2.55 1.83 1.27 .58 .22 .05
D16S520 4.39 2.84 1.87 1.41 .74 .28 .06
D16S3091 5.91 4.15 2.36 1.38 .47 .09 .05
( at ), D16S3068 ( at ),Z = 2.00 v = 0 Z = 3.30 v = 0max max
and D16S503 ( at ). The last five mark-Z = 1.35 v = .1max
ers were all adjacent on chromosome 16 and thus defined
a 54-cM region of interest with a significant maximum
two-point LOD score for marker D16S3068 (table 2).
We then analyzed the genotypes of D16S3068 for 48
subjects of kindreds 2, 3, and 4. The maximum two-
point LOD score for all families, assuming heterogeneity,
was 4.33 at . We found significant evidence forv = .01
locus heterogeneity ( , df 1, ) and an2x = 5.91 P ! .02
estimated proportion of 60% of families having linkage.
When each family was analyzed separately (table 3),
with the five markers that gave positive LOD scores
in kindred 1 (D16S3075, D16S3103, D16S3046,
D16S3068, and D16S503), kindred 2 showed suggestive
linkage at marker D16S3068 ( at ), kin-Z = 2.02 v = 0max
dred 4 gave a positive LOD score at marker D16S3103
( at ) but a nonsignificant negative LODZ = 1.33 v = 0max
score at marker D16S3068 ( at ). Kin-Z = 0.29 v = 0
dred 3 led to exclusion of linkage at marker D16S3068
( at ). Given the evidence for linkage ofZ = 2.44 v = 0
MMVP to a locus on the short arm of chromosome 16
and associated heterogeneity, we therefore propose that
this locus be designated MMVP-1.
Multipoint and Haplotype Analyses
We refined the location of the MMVP-1 locus by a
multipoint linkage analysis of the two families that
showed linkage (kindreds 1 and 2) with nine additional
markers spanning 25 cM (fig. 3). With the conservative
model, a maximum multipoint LOD score of 5.45 was
obtained at the location of marker D16S3133 (adjacent
to D16S3068) when data on the two families were com-
bined. The multipoint LOD score was also maximum
for D16S3133, with the stringent model ( ).Z = 5.68max
The 1-LOD-unit and 3-LOD-unit support intervals
spanned 4.6 cM and 48.3 cM, respectively, with the
conservative model and spanned 4.2 cM and 21.9 cM
with the stringent model.
These results were supported by the haplotype anal-
yses. The MMVP-1 locus was a sex-averaged 5-cM in-
terval between D16S3068 and D16S420 in kindred 1
that included D16S3133 and mapped to chromosome
16p12.1-p11.2, as shown by the recombination events
in individuals IV.6 and III.9 (fig. 2a). However, given the
age-dependent penetrance of MMVP demonstrated in
our families, it must be noted that this minimal interval
partly relies on the unaffected individual IV.6. A max-
imal 34-cM interval can be defined by another recom-
bination event proximal to D16S404 in affected indi-
vidual III.8. In kindred 2, recombination events in
individuals II.3, II.6, II.7, and II.8 defined a larger cos-
egregation interval (42 cM) that still included the
MMVP-1 locus (fig. 2b). Haplotypes were also drawn
for the six unaffected subjects from kindred 1 who were
aged !40 years (individuals IV.8, IV.9, IV.10, IV.11, V.2,
and V.3), although these individuals were not included
in the previous statistical analyses; three unaffected sub-
jects aged !30 years had the disease allele, whereas no
recombinant was found among older subjects or in the
preceding generation. This was compatible with the ob-
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Figure 3 Refined location of the MMVP-1 locus. A multipoint linkage analysis comparing the segregation of MMVP and 20 marker loci
was performed with the assumption of two modes of inheritance. Only families that showed linkage to D16S3068 (kindreds 1 and 2) were
included in this analysis. The map of marker loci used and the distances in centimorgans are indicated below the plots of multipoint LOD
score; the full curve indicates LOD score calculated with the conservative model and the dotted line indicates LOD score calculated with the
stringent model; a bar represents the 1-LOD-unit support interval for the location of MMVP-1.
servation that penetrance of MMVP is low at age !30
years, at least in the families we studied.
The same markers of chromosome 16 were analyzed
in kindred 4, since linkage could not be formally ex-
cluded in this family. Two-point LOD scores were 11
for two markers, D16S3133 and D16S3103, with the
conservative model of inheritance. However, haplotype
analysis clearly showed that the MMVP-1 locus de-
scribed above does not cosegregate with MMVP in kin-
dred 4 (data not shown).
Discussion
This first mapping of a gene for nonsyndromic au-
tosomal dominant mitral-valve prolapse represents a
first step toward the identification of genes involved in
that heterogeneous group of diseases. Since Barlow’s de-
scription (1963), a variety of names have been given to
mitral-valve prolapse, including “the click-murmur syn-
drome,” “the floppy mitral-valve syndrome,” “myxo-
matous mitral valve,” and “idiopathic mitral-valve pro-
lapse.” This reflects the uncertainty about its
pathophysiology (Alpert et al. 1998). We decided to use
the term “myxomatous mitral-valve prolapse” (MMVP)
because our aim was to focus on the abnormality of the
mitral-valve structure and not on its possible functional
dynamic consequences (i.e., prolapse and/or mitral in-
sufficiency). By excluding patients with connective-tissue
disorders (e.g., Marfan and Ehler-Danlos syndromes) by
means of a careful clinical examination and by selecting
patients related to a proband with surgically proven
MMVP and families demonstrating autosomal inheri-
tance, we restricted our analysis to a more homogeneous
entity and possibly increased our chance to identify a
responsible locus. This strategy proved to be successful
and, together with another locus responsible for X-trans-
mitted valvular dystrophy (Kyndt et al. 1998), should
help clarify the nosology of mitral-valve prolapse.
The analysis of four pedigrees allowed us to find a
positive linkage with the chromosome 16p11.2-12.1 re-
gion. A positive two-point linkage was already apparent
in kindred 1, with a LOD score of 3.30 at withv = 0
D16S3068. A positive LOD score was also evident in
kindred 2, in which we found at , for anZ = 2.02 v = 0
expected . Kindred 4 was more problematic,Z = 2.06max
because we could not exclude linkage. Moreover, with
the conservative model, this family had a 40% proba-
bility of being linked to D16S3068. We therefore per-
formed a separate haplotype analysis in kindred 4 and
found no cosegregation interval that overlapped with
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the MMVP-1 locus. Even though kindreds 1 and 2 were
linked to the same locus, they did not share the same
haplotype and had clearly different origins (Central Eu-
rope and western France, respectively), thus making the
presence of a common ancestral mutation very unlikely.
Penetrance of MVP has been related to age and sex
(Devereux et al. 1982). In the largest familial study con-
ducted so far, echocardiographic mitral prolapse was
present in 54 (30%) of 179 first-degree relatives of 45
affected probands (Devereux et al. 1982). Its presence
was significantly higher in women (41%) than in men
(19%) and was more common in adults (35%) than in
children (8%). In our limited sample of four families,
we could not confirm the effect of sex, as the number
of affected men ( ) was even greater than the num-n = 16
ber of affected women ( ). On the contrary, we ob-n = 9
served an age-dependent penetrance in our families but
could not evaluate it precisely. Therefore, unaffected in-
dividuals from the youngest generation were not taken
into account in the first-stage genomewide scan. Al-
though less powerful, this method allowed us to dem-
onstrate significant linkage. We also performed various
multipoint linkage analyses that included the youngest
unaffected subjects, assuming different models of age-
dependent penetrance and thus simulating the data
observed in our family (low penetrance for young sub-
jects, high penetrance for older subjects). These addi-
tional analyses did not alter the previous results, since
there was still evidence for linkage to D16S3133 (Z =
.94–5.80, assuming a maximum penetrance after the4
ages of 30 and 60 years, respectively). Haplotype anal-
yses finally showed that the disease was rarely expressed
in young adults aged !30 years.
The mild level of derangement of the mitral-valve
structure in the vast majority of subjects (Levy and Sav-
age 1987), together with the possibility of false positive
diagnosis by two-dimensional echocardiography (Nish-
imura et al. 1985; Levine et al. 1988), has led both to
various estimations of the prevalence of mitral-valve
prolapse and to the need for new surgical (Carpentier
et al. 1980) and echocardiographic (Perloff et al. 1986)
classifications. In a recent familial echocardiographic
study of mitral-valve prolapse, relatives of index cases
with AML 15 mm thick were affected significantly more
often than were the relatives of other index cases (Zup-
piroli et al. 1998). However, leaflet thickening per se
was not a heritable characteristic identifying distinct sub-
types, because both groups of relatives had similar ech-
ocardiographic leaflet characteristics. Our study con-
firms these findings at the phenotypic and molecular
levels. Even though the four probands had typical an-
atomical features of MMVP at surgery, echocardio-
graphic thickness of the AML varied from one kindred
to another, with higher values in affected relatives of
kindred 2 compared with those of the other three kin-
dreds. These phenotypic differences did not explain the
genetic heterogeneity of MMVP: both kindreds 1 and 2
were linked to the MMVP-1 locus, whereas linkage was
excluded in kindred 3 and cosegregation of MMVP-1
locus with MMVP was excluded in kindred 4.
Our study demonstrates the genetic heterogeneity of
the autosomal dominant forms of MMVP, and several
genes are likely to be implicated in that disease. Thus,
the presence of myxomatous tissue and the correspond-
ing histological changes observed in MMVP are prob-
ably not specific and have already been attributed to
different abnormalities, such as variations in either the
morphology of the mitral annulus (Hutchins et al. 1986)
or the thickness of the zona spongiosa of the mitral
leaflet (Olsen and Al-Rufaie 1980). Mitral-valve pro-
lapse has been found in several, but not all, affected
members of a large family with dilated cardiomyopathy
mapping to chromosome 10q21-23 (Bowles et al. 1996).
In this family, it was not possible to distinguish whether
the association was coincidental, secondary to the ven-
tricular dysfunction, or part of a genetic defect causing
both dilated cardiomyopathy and mitral-valve prolapse.
Mitral-valve prolapse has also been associated with con-
nective-tissue disorders and a variety of congenital in-
tracardiac anomalies (Glesby and Pyeritz 1989).
The genes involved in the structure or development
of atrioventricular valves are therefore candidate genes
for MMVP. However, none of the corresponding genes
have been mapped to a region that could correspond to
the MMVP-1 locus. Advances in the Human Genome
Project should facilitate a positional candidate-gene ap-
proach. So far, the Institute of Genome Research has
mapped more than 24 genes to the region overlapping
the MMVP-1 5-cM interval. It is interesting to note that
among these genes, sialophorin, the CD11 integrin clus-
ter, CD19, and the interleukin-4 receptor are involved
in cellular adhesion and the immune response and have
been suggested as candidate genes for Crohn disease, an
inflammatory bowel disease that maps to the pericen-
tromeric region of chromosome 16 (Hugot et al. 1996).
Cardiotrophin-1, a member of the family of cytokines,
is present in the heart during embryogenesis (Pennica et
al. 1995) and may play a role in cardiac hypertrophy.
In addition, 110 genes with as-yet-unknown products
and a large number of ESTs could provide other rea-
sonable candidates. The gene putatively responsible for
pseudoxanthoma elasticum has been mapped to a region
overlapping our more secure 35-cM interval (Struk et
al. 1997). Although vascular and cardiac lesions have
been reported in that disease, they do not resemble those
observed in MMVP. Finally, the myosin heavy-chain 11
and other genes coding for transcription factors could
also be evaluated.
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